Thank you for Subscribing to Life Science Review Weekly Brief
After the pandemic outbreak, the pharmaceutical industry is on the radar, which raises the highest expectations to keeping under control and minimizing the risks.
Fremont, CA: The impact of the pandemic on the pharmaceutical industry is an additional reason for companies to deal precisely with the incumbent economic damage and to strive to place themselves among the 47 percent “rising stars” during turbulent times of the economic crisis, and not among the 89 percent “sinking ships.”
Pharmaceutical companies depend on automation to conduct a range of functions, such as supporting clinical testing to amp up vaccine development or accelerating data entry and analysis.
Foster individualized marketing
Software robots can imitate medical companions for patients, giving relevant information, customized to what each patient needs to know. Intelligent automation enables the usage of chatbots that can take one step further to provide customer-specific data, make sure that the patients get all and only the data that is relevant for them.
Giving patients real-time knowledge that is made to fit their own needs, and bots act as virtual medical companions. This provides customers with a personalized experience. As a result, the pharma company will itself achieve a higher standing.
Facilitate clinical development
This includes the processes focused on drug development and drug approval that are underpinned by clinical trials. Therefore, it has a top priority in the value chain of life sciences and is also very costly.
Software robots can conduct menial tasks like data entry or quality control very fast and with maximal accuracy. This efficiency bonus changes into substantial savings for clinical trials. Also, bots can perform a large-scale interpretation and processing of clinical trial data, for instance, radiology reports, and facilitate the identification of high-risk abnormalities in images.
Amplify sales representatives’ responsiveness
There is a stringent requirement for this because more than 70 percent of pharmaceutical reps’ time is invested in dull, time-consuming tasks like data entry. As a result, their power to discuss with the customers and offer customers services is diminishing. Suppose bots are used to do inventories, retrieve timely and accurate sales data, record tracking customer feedback, or manage orders and inventory. In that case, sales reps could put more energy into the more value-added tasks that need human-to-human communication, such as customer engagement and conversions. By doing this, RPA enables improved sales efficiency.